background: Stent thrombosis (ST) has been described as a rare event in the current percutaneous coronary intervention (PCI) era; however, its occurrence has been associated with increased morbimortality. Our purpose was to identify the predictors of ST in a large cohort of patients treated with drug-eluting stents (DES) in daily practice.
methods:
A total of 5,614 pts (9,045 lesions) undergoing elective for emergency PCI solely with DES (n=9,680) as a default strategy were enrolled between May/02-Aug/14. Clinical follow-up (FU) was performed at 1, 6 and 12 months and yearly up to 12 years (97%). ST was defined according to the propositions of the Academic Research Consortium. results: Mean age was 64.6 years, 32% had diabetes, 21.4% had previous myocardial infarction (MI) (≥30 days), and 42% had acute coronary syndrome or recent MI (<30 days). Overall, the incidence of ST was 2.4% (n=133), given that 95% of patients were ST-free up to 12 years follow-up (Kaplan-Meier estimate). The predictors of early (<30 days), late (1 to 12 months) and very late ST (>12 months) are shown in the Table. Conclusion: The occurrence of ST up to 12 years was relatively low (2.4%) and significantly associated with history of cardiovascular disease, diabetes, recent MI and total stent length at an early phase; prior PCI, recent MI, SVG, lesion complexity and stent type between 1 and 12 months; and prior PCI, recent MI and total stent length more than 12 months. 
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